Harvard
Medical School just got an F from the American Medical Student Association, which
rates how well medical schools monitor and control drug industry money.
Its chief rivals fared better, with the AMSA awarding an A to the University of
Pennsylvania, Bs to Stanford, Columbia, and New York University, and a C
to Yale.
According to faculty and administrators interviewed by The New
York Times, Harvard has been swayed because its teaching hospitals are independent
and because reforms could cut funding from big pharma firms, or drive faculty
to defect.
First-year Harvard Medical student David Tian, 24, said to
the Times: Before coming here, I had no idea how much influence companies
had on medical education. And its something thats purposely meant
to be under the table ... (Wilson D 2009)
As Time magazine put
it, it turns out that many professors and instructors are, legally,
on the dole as well, and students are beginning to worry that what they're being
taught is just as one-sided as what patients are being prescribed. (Kluger
J 2009)
The drug companies
influence over academia is only part of the unfortunate picture.
Many
Congresspersons take drug money -- few other corporations spend more on lobbying
and campaigns -- so it is unsurprising that its members make the legislative and
funding decisions they do.
These bad decisions essentially bar highly
promising -- but non-patentable -- foods and nutritional supplements from getting
the costly research needed to gain FDA approval as legitimate preventive and/or
therapeutic agents.
Instead, the public is force-fed a false belief in
the synthetic drugs made by well-heeled private firms with the $250 million-plus
it takes to gain FDA approval of health claims which are highly lucrative
only with regard to single, patentable chemicals.
Why isnt Congress
spending relatively small sums to pay universities to conduct the Phase I, II,
and III clinical trials needed to gain approval for health claims?
This
money would be paid back a thousand-fold in greatly reduced healthcare costs to
Medicare.
Naturally, the politicians campaign-finance patrons in
big pharma firms dont want them to support creation of any non-patentable
competitions.
So here the American people sit at the tender mercies
of Pfizer, Merck, and company. Its sad, really.
Even the laudable
med students behind the scorecard dont go nearly far enough.
Their
list of Federal policy recommendations doesnt even touch on the research-funding
and patent issues related to natural products and supplements.
At least
they're a step in the right direction!
Editor's
note: We
consider organic whole foods from both plant and animal kingdoms to be a major
key to superior health. We also think it's terribly important to eat fish at least
twice a week to get the essential fatty acids. Here at our house, we only eat
wild Alaskan salmon and other wild seafoods from our friends at Vital Choice.
Click here
to visit Vital Choice Seafood.
Sources:
American Medical
Student Association (AMSA). Conflict of interest policies at academic medical
centers. Accessed online at http://www.amsascorecard.org/
Kluger J. Time.
March 06, 2009. Is Drug-Company Money Tainting Medical Education? Accessed online
at http://www.time.com/time/health/article/0,8599,1883449,00.html
Wilson
D. Harvard Medical School in Ethics Quandary. Accessed online at http://www.nytimes.com/2009/03/03/business/03medschool.html
Click
Here to
share this page with your friends, website visitors, ezine readers, social followers
and other online contacts.
Disclaimer:
Throughout this website, statements are made pertaining to the properties and/or
functions of food and/or nutritional products. These statements have not been
evaluated by the Food and Drug Administration and these materials and products
are not intended to diagnose, treat, cure or prevent any disease.